Cargando…

A Novel Neurotrophic Drug for Cognitive Enhancement and Alzheimer's Disease

Currently, the major drug discovery paradigm for neurodegenerative diseases is based upon high affinity ligands for single disease-specific targets. For Alzheimer's disease (AD), the focus is the amyloid beta peptide (Aß) that mediates familial Alzheimer's disease pathology. However, given...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Qi, Prior, Marguerite, Dargusch, Richard, Roberts, Amanda, Riek, Roland, Eichmann, Cédric, Chiruta, Chandramouli, Akaishi, Tatsuhiro, Abe, Kazuho, Maher, Pamela, Schubert, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3237323/ https://www.ncbi.nlm.nih.gov/pubmed/22194796 http://dx.doi.org/10.1371/journal.pone.0027865

Ejemplares similares

The neurotrophic compound J147 reverses cognitive impairment in aged Alzheimer's disease mice
por: Prior, Marguerite, et al.
Publicado: (2013)

Modulation of p25 and inflammatory pathways by fisetin maintains cognitive function in Alzheimer’s disease transgenic mice
por: Currais, Antonio, et al.
Publicado: (2014)

The mitochondrial ATP synthase is a shared drug target for aging and dementia
por: Goldberg, Joshua, et al.
Publicado: (2018)

Geroprotective effects of Alzheimer’s disease drug candidates
por: Kepchia, Devin, et al.
Publicado: (2021)

A novel Alzheimer’s disease drug candidate targeting inflammation and fatty acid metabolism
por: Daugherty, Daniel, et al.
Publicado: (2017)

A comprehensive multiomics approach toward understanding the relationship between aging and dementia
por: Currais, Antonio, et al.
Publicado: (2015)

Detergent/Nanodisc Screening for High-Resolution NMR Studies of an Integral Membrane Protein Containing a Cytoplasmic Domain
por: Tzitzilonis, Christos, et al.
Publicado: (2013)

Diverse proteins aggregate in mild cognitive impairment and Alzheimer’s disease brain
por: Kepchia, Devin, et al.
Publicado: (2020)

Multi‐Dimensional Structure and Dynamics Landscape of Proteins in Mammalian Cells Revealed by In‐Cell NMR
por: Kadavath, Harindranath, et al.
Publicado: (2022)

Fisetin Lowers Methylglyoxal Dependent Protein Glycation and Limits the Complications of Diabetes
por: Maher, Pamela, et al.
Publicado: (2011)

Structural insights into α-synuclein monomer–fibril interactions
por: Kumari, Pratibha, et al.
Publicado: (2021)

Neurotrophic delivery in Alzheimer’s-model mice
por: Konofagou, Elisa, et al.
Publicado: (2015)

The effect of dietary supplementation on brain-derived neurotrophic factor and cognitive functioning in Alzheimer's dementia
por: Martin, Alicia, et al.
Publicado: (2017)

Correlation of neurotrophic and neuropsychological parameters in alzheimer’s disease
por: Sidenkova, A.
Publicado: (2021)

Difference in Methylation and Expression of Brain-Derived Neurotrophic Factor in Alzheimer’s Disease and Mild Cognitive Impairment
por: Kouter, Katarina, et al.
Publicado: (2023)

Neurotrophic factors in Alzheimer’s disease: role of axonal transport
por: Schindowski, K, et al.
Publicado: (2008)

Hydrogen sulfide and polysulfides induce GABA/glutamate/d-serine release, facilitate hippocampal LTP, and regulate behavioral hyperactivity
por: Furuie, Hiroki, et al.
Publicado: (2023)

Amitriptyline-Mediated Cognitive Enhancement in Aged 3×Tg Alzheimer's Disease Mice Is Associated with Neurogenesis and Neurotrophic Activity
por: Chadwick, Wayne, et al.
Publicado: (2011)

Systemic brain derived neurotrophic factor but not intestinal barrier integrity is associated with cognitive decline and incident Alzheimer’s disease
por: Voigt, Robin M., et al.
Publicado: (2021)

Neurotrophic and Neuroprotective Actions of (−)- and (+)-Phenserine, Candidate Drugs for Alzheimer’s Disease
por: Lilja, Anna M., et al.
Publicado: (2013)

Neurotrophic factors in Alzheimer's and Parkinson's diseases: implications for pathogenesis and therapy
por: Sampaio, Tuane Bazanella, et al.
Publicado: (2017)

Neurotrophic, Gene Regulation, and Cognitive Functions of Carboxypeptidase E-Neurotrophic Factor-α1 and Its Variants
por: Xiao, Lan, et al.
Publicado: (2019)

Brain-Derived Neurotrophic Factor Serum Levels and Hippocampal Volume in Mild Cognitive Impairment and Dementia due to Alzheimer Disease
por: Borba, Ericksen Mielle, et al.
Publicado: (2016)

Hyperoxygenation revitalizes Alzheimer’s disease pathology through the upregulation of neurotrophic factors
por: Choi, Juli, et al.
Publicado: (2019)

Brain-derived neurotrophic factor in Alzheimer’s disease and its pharmaceutical potential
por: Gao, Lina, et al.
Publicado: (2022)

Exogenous brain-derived neurotrophic factor attenuates cognitive impairment induced by okadaic acid in a rat model of Alzheimer's disease
por: Xu, Ai-Hua, et al.
Publicado: (2018)

Analysis of Effect of Intensity of Aerobic Exercise on Cognitive and Motor Functions and Neurotrophic Factor Expression Patterns in an Alzheimer’s Disease Rat Model
por: Lee, Do-Youn, et al.
Publicado: (2023)

Brain-derived Neurotrophic Factor in Megakaryocytes
por: Chacón-Fernández, Pedro, et al.
Publicado: (2016)

Brain-Derived Neurotrophic Factor-Mediated Cognitive Impairment in Hypothyroidism
por: Madhusudhan, U, et al.
Publicado: (2022)

Neuroprotective, Anti-Amyloidogenic and Neurotrophic Effects of Apigenin in an Alzheimer’s Disease Mouse Model
por: Zhao, Le, et al.
Publicado: (2013)

Alzheimer’s Disease: Challenges and a Therapeutic Opportunity to Treat It with a Neurotrophic Compound
por: Baazaoui, Narjes, et al.
Publicado: (2022)

Trichinella spiralis and T. britovi in North-Eastern Romania: A Six-Year Retrospective Multicentric Survey
por: Iacob, Olimpia, et al.
Publicado: (2022)

Entropy Derived from Causality
por: Riek, Roland
Publicado: (2020)

Prevention of dendritic and synaptic deficits and cognitive impairment with a neurotrophic compound
por: Baazaoui, Narjes, et al.
Publicado: (2017)

Characterizing the Role of Brain Derived Neurotrophic Factor Genetic Variation in Alzheimer’s Disease Neurodegeneration
por: Honea, Robyn A., et al.
Publicado: (2013)

Brain-derived neurotrophic factor protects against tau-related neurodegeneration of Alzheimer's disease
por: Jiao, S-S, et al.
Publicado: (2016)

Can Co-Activation of Nrf2 and Neurotrophic Signaling Pathway Slow Alzheimer’s Disease?
por: Murphy, Kelsey E., et al.
Publicado: (2017)

Prenatal to early postnatal neurotrophic treatment prevents Alzheimer-like behavior and pathology in mice
por: Wei, Wei, et al.
Publicado: (2020)

Neuroprotective activity of Ulmus pumila L. in Alzheimer's disease in rats; role of neurotrophic factors
por: Hussein, Rehab A., et al.
Publicado: (2020)

Amyloidogenesis and Neurotrophic Dysfunction in Alzheimer’s Disease: Do They have a Common Regulating Pathway?
por: Jiao, Fengjuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_988u1icijdokicc6d25ltqg7ro